Great Valley Advisor Group Inc. Sells 3,597 Shares of CVS Health Co. (NYSE:CVS)

Great Valley Advisor Group Inc. lowered its position in shares of CVS Health Co. (NYSE:CVS) by 33.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,134 shares of the pharmacy operator’s stock after selling 3,597 shares during the quarter. Great Valley Advisor Group Inc.’s holdings in CVS Health were worth $449,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the third quarter worth $25,000. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the 3rd quarter valued at $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the 3rd quarter worth about $32,000. First Community Trust NA grew its position in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the period. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health during the third quarter worth about $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of a number of research reports. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Barclays decreased their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Truist Financial reaffirmed a “buy” rating and set a $67.00 price target (down previously from $76.00) on shares of CVS Health in a research report on Wednesday, November 20th. Royal Bank of Canada decreased their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Finally, Evercore ISI increased their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $70.33.

CVS Health Stock Performance

CVS Health stock opened at $59.02 on Wednesday. The firm has a fifty day simple moving average of $59.26 and a two-hundred day simple moving average of $58.69. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25. The company has a market capitalization of $74.27 billion, a PE ratio of 14.98, a P/E/G ratio of 0.98 and a beta of 0.55. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the previous year, the firm earned $2.21 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. Research analysts expect that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.51%. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.